Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
A clinical trail to investigate the influence of SLCO2B1 polymorphism on the pharmacokinetic
characteristics of voriconazole in CYP2C19 poor metabolizers